UNSPSC 85892210: High dose rate (hdr) brachytherapy of salivary glands using iodine 125 (i-125)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of high dose rate (hdr) brachytherapy of salivary glands using iodine 125 (i-125). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code D91699Z

UNSPSC 85892210 High dose rate (HDR) brachytherapy of salivary glands using iodine 125 (I-125) is a Commodity code. The recent state and local procurement activity under this code shows a substantial mismatch: the single recorded opportunity does not involve brachytherapy, oncology staffing, or salivary-gland treatment at all. Instead, the County of Santa Clara Health System posted RFSQHHSFY270052 in July 2026 to establish a qualified vendor pool for temporary ancillary health professional staffing services — roles such as audiology, cardiology technicians, diagnostic imaging technicians, respiratory care, and therapy services. The code's nominal scope addresses a highly specialized clinical oncology procedure, yet the actual procurement activity being tagged under it targets broad-based clinical support staffing across multiple specialties, with no connection to radiation oncology or brachytherapy.

The geographic activity is limited to California (Santa Clara County). The County of Santa Clara Health System is the sole issuing body visible in the recent opportunities block. The solicitation opened July 7, 2026, with proposals due October 7, 2026, and operates as a non-exclusive, multiple-award qualification vehicle with no guaranteed contract volume; selected vendors are placed on a Qualified List maintained for up to five years, with actual engagements negotiated case-by-case. Given the disconnect between the code's specialty oncology focus and the staffing services actually being procured, this code shows little relevant recent activity for firms in brachytherapy or oncology-specific service lines.